Noted that epigenetic modifiers such as DTAI (DNMT3A, TET2, ASXL1, and/or IDH1 or IDH2) are the most prevalent AML-initiating mutation and the combination of them may confer clonal dominance. This evidence concerns the gene IDH2 and acute myeloid leukemia.